PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H0) ("PreveCeutical"), a health sciences company that develops ...

The FDA accepted a Biologics License Application for imlifidase for the desensitization treatment of highly sensitized adult kidney transplant patients.

Supporting Data: Women pay $15 billion more annually; average female employee spends 18% more out-of-pocket. Gaps in healthcare are forcing women to spend more to maintain their health, but one ...

Ste’Aira Ballard’s mother, Tamala Smith, died less than two weeks after having liposuction and a fat transfer procedure performed at a California cosmetic surgery clinic. (Nic Antaya for KFF Health ...

Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear.

VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 ...